Neuen BL, et al. Circulation 2024; 150: 1781–1790
Cardiovascular, kidney, and safety outcomes with GLP-1 receptor agonists alone and in combination with SGLT2 inhibitors in type 2 diabetes: A systematic review and meta-analysis
Grandangolo in Nefrologia, Dialisi e Trapianto
Newsletter
©Accademia Nazionale di Medicina | Provider ECM Nazionale N° 31 | Tutti i diritti riservati | Webmaster | Privacy policy | Powered by Forum Service